95 related articles for article (PubMed ID: 2051994)
1. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
Jansen RW; Molema G; Pauwels R; Schols D; De Clercq E; Meijer DK
Mol Pharmacol; 1991 Jun; 39(6):818-23. PubMed ID: 2051994
[TBL] [Abstract][Full Text] [Related]
2. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
4. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
5. Charge modification of plasma and milk proteins results in antiviral active compounds.
Swart PJ; Harmsen MC; Kuipers ME; Van Dijk AA; Van Der Strate BW; Van Berkel PH; Nuijens JH; Smit C; Witvrouw M; De Clercq E; de Béthune MP; Pauwels R; Meijer DK
J Pept Sci; 1999 Dec; 5(12):563-76. PubMed ID: 10628656
[TBL] [Abstract][Full Text] [Related]
6. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus.
Wilks D; Walker L; O'Brien J; Habeshaw J; Dalgleish A
Immunology; 1990 Sep; 71(1):10-5. PubMed ID: 2210798
[TBL] [Abstract][Full Text] [Related]
7. A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region.
Parish CR; Low L; Warren HS; Cunningham AL
J Immunol; 1990 Aug; 145(4):1188-95. PubMed ID: 2380554
[TBL] [Abstract][Full Text] [Related]
8. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
[TBL] [Abstract][Full Text] [Related]
9. An anti-CD4 (CDR3-loop) monoclonal antibody inhibits human immunodeficiency virus type 1 envelope glycoprotein-induced apoptosis.
Guillerm C; Robert-Hebmann V; Hibner U; Hirn M; Devaux C
Virology; 1998 Sep; 248(2):254-63. PubMed ID: 9721234
[TBL] [Abstract][Full Text] [Related]
10. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I
J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839
[TBL] [Abstract][Full Text] [Related]
11. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.
Corbeau P; Benkirane M; Weil R; David C; Emiliani S; Olive D; Mawas C; Serre A; Devaux C
J Immunol; 1993 Jan; 150(1):290-301. PubMed ID: 7678031
[TBL] [Abstract][Full Text] [Related]
12. Guanine-rich oligonucleotide modified at the 5' terminal by dimethoxytrityl residue inhibits HIV-1 replication by specific interaction with the envelope glycoprotein.
Agatsuma T; Yamamoto I; Furukawa H; Nishigaki T
Antiviral Res; 1996 Jul; 31(3):137-48. PubMed ID: 8811198
[TBL] [Abstract][Full Text] [Related]
13. Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged human serum albumins (NCAs) and AZT.
Kuipers ME; Swart PJ; Witvrouw M; Esté JA; Reymen D; De Clercq E; Meijer DK
J Drug Target; 1999; 6(5):323-35. PubMed ID: 10342381
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.
Schols D; Wutzler P; Klöcking R; Helbig B; De Clercq E
J Acquir Immune Defic Syndr (1988); 1991; 4(7):677-85. PubMed ID: 1675677
[TBL] [Abstract][Full Text] [Related]
15. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
Cabrera C; Witvrouw M; Gutiérrez A; Clotet B; Kuipers ME; Swart PJ; Meijer DK; Desmyter J; De Clercq E; Esté JA
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1535-43. PubMed ID: 10580404
[TBL] [Abstract][Full Text] [Related]
16. Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry.
Schols D; Pauwels R; Baba M; Desmyter J; De Clercq E
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2397-408. PubMed ID: 2789268
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120.
Kuipers ME; Huisman JG; Swart PJ; de Béthune MP; Pauwels R; Schuitemaker H; De Clercq E; Meijer DK
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):419-29. PubMed ID: 8605586
[TBL] [Abstract][Full Text] [Related]
18. [Virtual screening of small molecular HIV-1 entry inhibitor NC-2 targeting gp120 and its action mechanism].
Duan H; Wang Y; Song D; Chen Z; Qiu J; Lu L; Jiang S; Liu S; Tan S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):826-31. PubMed ID: 23803191
[TBL] [Abstract][Full Text] [Related]
19. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
Schols D; Pauwels R; Desmyter J; De Clercq E
Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563
[TBL] [Abstract][Full Text] [Related]
20. The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins.
Beljaars L; Floris R; Berkhout B; Smit C; Meijer DK; Molema G
Biochem Pharmacol; 2002 May; 63(9):1663-73. PubMed ID: 12007569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
